The purpose of the panel was to provide insight into how some health care systems are paving the way for value-based care.
Matthew Binnicker, Ph.D., Director of the Clinical Virology Laboratory in the Division of Clinical Microbiology at Mayo Clinic, recently spoke with Consultant360 regarding testing for viral gastroenteritis.
Elitza Theel, Ph.D., Director of the Infectious Diseases Serology Laboratory, discusses eastern equine encephalitis virus, which is spread via mosquito bite.
Mayo Clinic Laboratories is thrilled to introduce “Lab Medicine Rounds.” This curated podcast for physicians, laboratory professionals, and students features trending topics from Mayo Clinic Laboratories subject-matter experts.
Dr. Pandey is a nuclear radiology researcher working with a team to develop a new radioactive tracer to detect prostate cancer.
Traditionally, Mayo Clinic’s Simulation Center is used for surgical procedures and teaching students how to run a code. Mayo Clinic pathology consultant Karen Fritchie, M.D., recently developed a new and innovative way to use the center.
Mayo Clinic startup company Vineti developed first-of-its-kind software package tracking for cell therapies. Vineti’s groundbreaking product captured a World Economic Forum Technology Pioneer Award in the field of health.
R. Ross Reichard, M.D., DLMP Vice Chair of Quality and Associate Chair of Practice, recently contributed to a College of American Pathologists (CAP) article in CAP Today. The article, “How the Laboratory Drives Patient Satisfaction,” explores the myriad ways laboratories can monitor and improve the patient experience.
Curtis Hanson, M.D., discusses the importance of detecting immunoglobulin heavy-chain variable region gene (IGHV) when acquiring prognostic and potentially therapeutic information in chronic lymphocytic leukemia (CLL) patients in CAP TODAY.
The current diagnostic tools in a pathologist’s arsenal sometimes cannot provide a clear distinction between primary mediastinal large B-cell lymphoma (one of the few lymphomas more common in younger women) and diffuse large B-cell lymphoma, the most common type of non-Hodgkin’s lymphoma overall.
The standard laboratory test to diagnose multiple myeloma dates back to the Eisenhower administration. Research at Mayo Clinic spearheaded by David Murray, M.D., Ph.D. (PATH ’10), and fueled by his experience as an industrial chemist has led to a new assay to screen and diagnose the disease.
Munson Healthcare, an eight-hospital system, has worked with Mayo Clinic Laboratories for more than 30 years. The system’s community hospital labs provide basic testing, but Munson turns to Mayo Clinic Laboratories for its highly specialized clinical lab test needs.
Around 5 o’clock each morning, approximately 500 cranberry colored boxes arrive at Rochester International Airport from the Federal Express hub in Memphis, Tennessee. The boxes, created by Mayo Clinic Laboratories to allow FedEx staff to identify high-priority patient specimens destined for Mayo Clinic Laboratories, originate at medical institutions around the world and contain 35,000 unique specimens to be tested or analyzed at one of more than 65 specialty labs at Mayo Clinic.